Clinical trial
Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole…
NCT00441285 · Universidad Peruana Cayetano Heredia, Other · Completed
Key facts
| NCT number | NCT00441285 |
|---|---|
| Title | Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) |
| Official title | Antiparasitic Therapy for Neurocysticercosis: Phase II/III Study on Safety and Efficacy of Combined Treatment With Praziquantel and Albendazole |
| Lead sponsor | Universidad Peruana Cayetano Heredia, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Neurocysticercosis, Epilepsy |
| Intervention type | Drug |
| Interventions | Praziquantel, Albendazole, ABZ Placebo, PZQ Placebo |
| Enrollment | 156 |
| Start date | Jan 1, 2010 |
| Primary completion | Dec 1, 2012 |
| Completion | Sep 1, 2013 |
| First posted | Feb 28, 2007 |
| Last update posted | Jun 11, 2015 |
| Countries | Peru |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: